KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nova (NVMI) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Nova (NVMI) over the last 17 years, with Q4 2025 value amounting to $22.3 million.

  • Nova's Cost of Revenue rose 3964.96% to $22.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $82.2 million, marking a year-over-year increase of 2629.9%. This contributed to the annual value of $82.2 million for FY2025, which is 2629.9% up from last year.
  • Per Nova's latest filing, its Cost of Revenue stood at $22.3 million for Q4 2025, which was up 3964.96% from $20.2 million recorded in Q3 2025.
  • Over the past 5 years, Nova's Cost of Revenue peaked at $22.3 million during Q4 2025, and registered a low of $9.1 million during Q3 2021.
  • For the 5-year period, Nova's Cost of Revenue averaged around $14.6 million, with its median value being $13.6 million (2022).
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 4905.41% in 2022, then plummeted by 875.21% in 2023.
  • Over the past 5 years, Nova's Cost of Revenue (Quarter) stood at $11.2 million in 2021, then grew by 26.7% to $14.2 million in 2022, then fell by 4.46% to $13.6 million in 2023, then rose by 17.67% to $16.0 million in 2024, then soared by 39.65% to $22.3 million in 2025.
  • Its last three reported values are $22.3 million in Q4 2025, $20.2 million for Q3 2025, and $19.9 million during Q2 2025.